期刊文献+

血塞通注射液联合扶正化瘀胶囊治疗肝纤维化39例 被引量:2

The clinical effect of liver fibrosis by xuesaitong injection combination with fuzheng huayu capsule
下载PDF
导出
摘要 目的探讨血塞通注射液联合扶正化瘀胶囊治疗肝纤维化的临床疗效。方法选取我中医院78例慢性乙型肝炎肝纤维化患者随机均分为实验组和对照组,每组39例。对照组在常规护肝治疗基础上加用扶正化瘀胶囊治疗。实验组在对照组基础上加用血塞通注射液治疗。观察患者体征及肝功能指标变化情况。结果实验组患者抗肝纤维化有效率为87.18%,对照组有效率为46.15%,两组相比,差异具有统计学意义(P<0.01)。两组患者肝功能指标均得到改善,治疗后24周效果优于12周效果(P<0.05);实验组患者治疗效果优于对照组(P<0.05)。结论血塞通注射液联合扶正化瘀胶囊治疗肝纤维化效果显著,值得临床推广。 Objective To explore the clinical effect of liver fibrosis by xuesaitong injection combination with fuzheng huayu capsule. Methods 78 cases of patients with liver fibrosis were randomly divided into experiment group (39 cases)and control group(39 cases). On the basis of general protect liver's methods, the control group were treated with fuzheng huayu capsule. On the basis of control group' treatment, the experiment group were treated by xuesaitong injection. The clinical sign and the index of liver were compared.Results The effective rate of anti-liver fibrosis in experiment group(87.18%) were higher than the control group(46.15%)(P<0.01). The index of liver were improved for the two groups, the effect in 24 weeks were better than the 12 weeks(P<0.05); The effect in experiment group were better than the control group (P<0.05)Conclusion It has significant effect for liver fibrosis by xuesaitong injection combination with fuzheng huayu capsule, and it is worth for clinical use.
作者 李蔚辉
出处 《中国中医药现代远程教育》 2014年第4期27-28,共2页 Chinese Medicine Modern Distance Education of China
关键词 血塞通注射液 扶正化瘀胶囊 肝纤维化 中医药疗法 Xuesaitong injection Fuzheng huayu capsule Liver fibrosis Clinical effect
  • 相关文献

参考文献4

二级参考文献15

共引文献1870

同被引文献34

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部